American Portfolios Advisors Enanta Pharmaceuticals Inc Transaction History

American Portfolios Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Mar 24, 2023	SELL	$60.08 - $88.17 $244,946 - $359,469	-4,077 Closed	0 $0
Q2 2019 Mar 24, 2023	BUY	$81.3 - $97.35 $331,460 - $396,895	4,077 New	4,077 $344 Million
Q1 2019 Mar 24, 2023	BUY	$69.08 - $105.66 $77,507 - $118,550	1,122 Added 41.08%	3,853 $368 Million
Q4 2018 Mar 24, 2023	BUY	$65.41 - $84.65 $178,634 - $231,179	2,731 New	2,731 $193 Million
Q2 2018 Mar 24, 2023	BUY	$81.85 - $120.51 $64,170 - $94,479	784 Added 91.91%	1,637 $190 Million
Q1 2018 Mar 24, 2023	BUY	$57.91 - $92.15 $49,397 - $78,603	853 New	853 $69 Million
Q4 2017 Mar 24, 2023	BUY	$45.65 - $59.37 $34,739 - $45,180	761	761 $44.7 Million

108

19.7M

9.7K

12.4K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $147M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.